Interleukin-6 (IL-6) is a cytokine that regulates growth, differentiation and apoptosis of various types of malignant tumors, including prostate carcinomas by activating the STAT and/or mitogen activated protein kinase (MAPK) signaling pathways. This evidence concerns the gene WNK2 and prostate carcinoma.